ID MHPC_ECOLI Reviewed; 288 AA. AC P77044; P71204; P77205; Q2MC75; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 14-DEC-2011, sequence version 4. DT 27-MAR-2024, entry version 169. DE RecName: Full=2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase {ECO:0000255|HAMAP-Rule:MF_01654}; DE EC=3.7.1.14 {ECO:0000255|HAMAP-Rule:MF_01654, ECO:0000269|PubMed:15663941}; DE AltName: Full=2-hydroxy-6-ketonona-2,4-diene-1,9-dioic acid 5,6-hydrolase {ECO:0000255|HAMAP-Rule:MF_01654}; DE AltName: Full=2-hydroxy-6-oxonona-2,4,7-triene-1,9-dioic acid 5,6-hydrolase {ECO:0000255|HAMAP-Rule:MF_01654}; DE AltName: Full=2-hydroxy-6-oxonona-2,4-diene-1,9-dioic acid 5,6-hydrolase {ECO:0000255|HAMAP-Rule:MF_01654}; GN Name=mhpC {ECO:0000255|HAMAP-Rule:MF_01654}; GN OrderedLocusNames=b0349, JW0340; OS Escherichia coli (strain K12). OC Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; OC Enterobacteriaceae; Escherichia. OX NCBI_TaxID=83333; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RA Kawamukai M.; RT "Complete sequence of the mhp operon."; RL Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION AS A HYDROLASE. RC STRAIN=K12 / CS520; RX PubMed=9098055; DOI=10.1128/jb.179.8.2573-2581.1997; RA Ferrandez A., Garcia J.L., Diaz E.; RT "Genetic characterization and expression in heterologous hosts of the 3-(3- RT hydroxyphenyl)propionate catabolic pathway of Escherichia coli K-12."; RL J. Bacteriol. 179:2573-2581(1997). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RA Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M., RA Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D., RA Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.; RT "Sequence of minutes 4-25 of Escherichia coli."; RL Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RX PubMed=9278503; DOI=10.1126/science.277.5331.1453; RA Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V., RA Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F., RA Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B., RA Shao Y.; RT "The complete genome sequence of Escherichia coli K-12."; RL Science 277:1453-1462(1997). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=16738553; DOI=10.1038/msb4100049; RA Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S., RA Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.; RT "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 RT and W3110."; RL Mol. Syst. Biol. 2:E1-E5(2006). RN [6] RP PROTEIN SEQUENCE OF 2-18, FUNCTION AS A HYDROLASE, BIOPHYSICOCHEMICAL RP PROPERTIES, AND SUBUNIT. RX PubMed=9315862; DOI=10.1021/bi971115r; RA Lam W.W., Bugg T.D.; RT "Purification, characterization, and stereochemical analysis of a C-C RT hydrolase: 2-hydroxy-6-keto-nona-2,4-diene-1,9-dioic acid 5,6-hydrolase."; RL Biochemistry 36:12242-12251(1997). RN [7] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF RP SER-44; SER-114; HIS-118 AND HIS-267, ACTIVE SITE, AND REACTION MECHANISM. RX PubMed=15663941; DOI=10.1016/j.jmb.2004.11.032; RA Li C., Montgomery M.G., Mohammed F., Li J.-J., Wood S.P., Bugg T.D.H.; RT "Catalytic mechanism of C-C hydrolase MhpC from Escherichia coli: kinetic RT analysis of His263 and Ser110 site-directed mutants."; RL J. Mol. Biol. 346:241-251(2005). RN [8] RP MUTAGENESIS OF ASN-113; PHE-177; ARG-192; CYS-265 AND TRP-268, AND RP CATALYTIC MECHANISM. RX PubMed=17029402; DOI=10.1021/bi061253t; RA Li C., Li J.-J., Montgomery M.G., Wood S.P., Bugg T.D.H.; RT "Catalytic role for arginine 188 in the C-C hydrolase catalytic mechanism RT for Escherichia coli MhpC and Burkholderia xenovorans LB400 BphD."; RL Biochemistry 45:12470-12479(2006). RN [9] RP X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 5-288 IN COMPLEX WITH A RP NON-CLEAVABLE SUBSTRATE ANALOG, MASS SPECTROMETRY, AND SUBUNIT. RX PubMed=15663942; DOI=10.1016/j.jmb.2004.11.033; RA Dunn G., Montgomery M.G., Mohammed F., Coker A., Cooper J.B., Robertson T., RA Garcia J.-L., Bugg T.D.H., Wood S.P.; RT "The structure of the C-C bond hydrolase MhpC provides insights into its RT catalytic mechanism."; RL J. Mol. Biol. 346:253-265(2005). CC -!- FUNCTION: Catalyzes the cleavage of the C5-C6 bond of 2-hydroxy-6- CC oxononadienedioate and 2-hydroxy-6-oxononatrienedioate, a dienol ring CC fission product of the bacterial meta-cleavage pathway for degradation CC of phenylpropionic acid. MhpC shows some selectivity for the CC carboxylate of the side chain. {ECO:0000269|PubMed:15663941, CC ECO:0000269|PubMed:9098055, ECO:0000269|PubMed:9315862}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(2Z,4E)-2-hydroxy-6-oxonona-2,4-dienedioate + H2O = (2Z)-2- CC hydroxypenta-2,4-dienoate + H(+) + succinate; Xref=Rhea:RHEA:34187, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30031, CC ChEBI:CHEBI:66887, ChEBI:CHEBI:67152; EC=3.7.1.14; CC Evidence={ECO:0000255|HAMAP-Rule:MF_01654, CC ECO:0000269|PubMed:15663941}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(2Z,4E,7E)-2-hydroxy-6-oxonona-2,4,7-trienedioate + H2O = CC (2Z)-2-hydroxypenta-2,4-dienoate + fumarate + H(+); CC Xref=Rhea:RHEA:34191, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:29806, ChEBI:CHEBI:66888, ChEBI:CHEBI:67152; EC=3.7.1.14; CC Evidence={ECO:0000255|HAMAP-Rule:MF_01654, CC ECO:0000269|PubMed:15663941}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=2.1 uM for 2-hydroxy-6-oxononadienedioate (at pH 8) CC {ECO:0000269|PubMed:9315862}; CC KM=6.8 uM for 2-hydroxy-6-oxononadienedioate (at pH 8) CC {ECO:0000269|PubMed:15663941}; CC Note=kcat is 28 sec(-1) for hydrolase activity with CC 2-hydroxy-6-oxononadienedioate as substrate. CC {ECO:0000269|PubMed:15663941}; CC -!- PATHWAY: Aromatic compound metabolism; 3-phenylpropanoate degradation. CC {ECO:0000255|HAMAP-Rule:MF_01654}. CC -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01654, CC ECO:0000269|PubMed:15663942, ECO:0000269|PubMed:9315862}. CC -!- MASS SPECTROMETRY: Mass=31717; Method=Electrospray; CC Evidence={ECO:0000269|PubMed:15663942}; CC -!- MISCELLANEOUS: MhpC is not a serine hydrolase (catalytic triad), as CC Ser-114 is a non-nucleophilic catalytic residue and Asp-239 is not CC involved in the catalytic mechanism. CC -!- SIMILARITY: Belongs to the AB hydrolase superfamily. MhpC family. CC {ECO:0000255|HAMAP-Rule:MF_01654, ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAB18073.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAA13054.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAE76131.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=CAA70749.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D86239; BAA13054.1; ALT_INIT; Genomic_DNA. DR EMBL; Y09555; CAA70749.1; ALT_INIT; Genomic_DNA. DR EMBL; U73857; AAB18073.1; ALT_INIT; Genomic_DNA. DR EMBL; U00096; AAC73452.3; -; Genomic_DNA. DR EMBL; AP009048; BAE76131.1; ALT_INIT; Genomic_DNA. DR PIR; E64762; E64762. DR RefSeq; NP_414883.5; NC_000913.3. DR RefSeq; WP_000121907.1; NZ_SSZK01000061.1. DR PDB; 1U2E; X-ray; 2.10 A; A/B/C/D=1-288. DR PDBsum; 1U2E; -. DR AlphaFoldDB; P77044; -. DR SMR; P77044; -. DR BioGRID; 4260729; 8. DR DIP; DIP-10207N; -. DR IntAct; P77044; 3. DR STRING; 511145.b0349; -. DR SwissLipids; SLP:000001887; -. DR ESTHER; ecoli-mhpc; Carbon-carbon_bond_hydrolase. DR MEROPS; S33.995; -. DR PaxDb; 511145-b0349; -. DR EnsemblBacteria; AAC73452; AAC73452; b0349. DR GeneID; 944954; -. DR KEGG; ecj:JW0340; -. DR KEGG; eco:b0349; -. DR PATRIC; fig|1411691.4.peg.1929; -. DR EchoBASE; EB4168; -. DR eggNOG; COG0596; Bacteria. DR HOGENOM; CLU_020336_13_2_6; -. DR InParanoid; P77044; -. DR OrthoDB; 5853561at2; -. DR PhylomeDB; P77044; -. DR BioCyc; EcoCyc:MHPCHYDROL-MONOMER; -. DR BioCyc; MetaCyc:MHPCHYDROL-MONOMER; -. DR BRENDA; 3.7.1.14; 2026. DR UniPathway; UPA00714; -. DR EvolutionaryTrace; P77044; -. DR PRO; PR:P77044; -. DR Proteomes; UP000000318; Chromosome. DR Proteomes; UP000000625; Chromosome. DR GO; GO:0005737; C:cytoplasm; IDA:EcoliWiki. DR GO; GO:0052823; F:2-hydroxy-6-oxonona-2,4,7-trienedioate hydrolase activity; IDA:EcoCyc. DR GO; GO:0018771; F:2-hydroxy-6-oxonona-2,4-dienedioate hydrolase activity; IDA:EcoCyc. DR GO; GO:0016787; F:hydrolase activity; IDA:EcoliWiki. DR GO; GO:0042803; F:protein homodimerization activity; IEA:InterPro. DR GO; GO:0019622; P:3-(3-hydroxy)phenylpropionate catabolic process; IMP:EcoCyc. DR GO; GO:0019380; P:3-phenylpropionate catabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0019439; P:aromatic compound catabolic process; IMP:EcoliWiki. DR Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1. DR HAMAP; MF_01654; MhpC; 1. DR InterPro; IPR029058; AB_hydrolase. DR InterPro; IPR000073; AB_hydrolase_1. DR InterPro; IPR000639; Epox_hydrolase-like. DR InterPro; IPR023791; MhpC_alpha/beta_hydrolase. DR PANTHER; PTHR43689:SF53; ALPHA_BETA-HYDROLASES SUPERFAMILY PROTEIN; 1. DR PANTHER; PTHR43689; HYDROLASE; 1. DR Pfam; PF00561; Abhydrolase_1; 1. DR PRINTS; PR00111; ABHYDROLASE. DR PRINTS; PR00412; EPOXHYDRLASE. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. PE 1: Evidence at protein level; KW 3D-structure; Aromatic hydrocarbons catabolism; Direct protein sequencing; KW Hydrolase; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:9315862" FT CHAIN 2..288 FT /note="2-hydroxy-6-oxononadienedioate/2-hydroxy-6- FT oxononatrienedioate hydrolase" FT /id="PRO_0000207054" FT ACT_SITE 267 FT /note="Proton acceptor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01654, FT ECO:0000269|PubMed:15663941" FT SITE 114 FT /note="Transition state stabilizer" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01654, FT ECO:0000269|PubMed:15663941" FT SITE 192 FT /note="Catalytic role in ketonization of the dienol FT substrate (substrate destabilization)" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01654, FT ECO:0000269|PubMed:15663941, ECO:0000269|PubMed:17029402" FT MUTAGEN 44 FT /note="S->A: 2-fold decrease in catalytic efficiency and FT more than 5-fold increase in affinity for the natural FT substrate." FT /evidence="ECO:0000269|PubMed:15663941" FT MUTAGEN 113 FT /note="N->A: 200-fold decrease in catalytic activity and FT almost 2-fold increase in affinity." FT /evidence="ECO:0000269|PubMed:17029402" FT MUTAGEN 113 FT /note="N->H: 350-fold decrease in catalytic activity and FT almost 2-fold increase in affinity." FT /evidence="ECO:0000269|PubMed:17029402" FT MUTAGEN 114 FT /note="S->A: Weakly active. 3-fold decrease in affinity. FT Fast ketonisation and slow C-C cleavage." FT /evidence="ECO:0000269|PubMed:15663941" FT MUTAGEN 114 FT /note="S->G: Weakly active. 3-fold decrease in affinity. FT Fast ketonisation and slow C-C cleavage." FT /evidence="ECO:0000269|PubMed:15663941" FT MUTAGEN 118 FT /note="H->A: More than 2-fold decrease in catalytic FT efficiency and 3-fold increase affinity." FT /evidence="ECO:0000269|PubMed:15663941" FT MUTAGEN 177 FT /note="F->D: 100-fold decrease in catalytic activity." FT /evidence="ECO:0000269|PubMed:17029402" FT MUTAGEN 177 FT /note="F->G: 4-fold and 8-fold decrease in catalytic FT activity and affinity, respectively." FT /evidence="ECO:0000269|PubMed:17029402" FT MUTAGEN 192 FT /note="R->K: 40-fold and 5-fold decrease in catalytic FT activity and affinity, respectively." FT /evidence="ECO:0000269|PubMed:17029402" FT MUTAGEN 192 FT /note="R->Q: 280-fold and 10-fold decrease in catalytic FT activity and affinity, respectively." FT /evidence="ECO:0000269|PubMed:17029402" FT MUTAGEN 265 FT /note="C->A: 2-fold decrease in catalytic activity and FT almost 2-fold increase in affinity." FT /evidence="ECO:0000269|PubMed:17029402" FT MUTAGEN 267 FT /note="H->A: Weakly active, 1000-fold decrease in catalytic FT efficiency. Very slow ketonisation and C-C cleavage." FT /evidence="ECO:0000269|PubMed:15663941" FT MUTAGEN 268 FT /note="W->G: 10-fold and 20-fold decrease in catalytic FT activity and affinity, respectively." FT /evidence="ECO:0000269|PubMed:17029402" FT CONFLICT 153 FT /note="E -> G (in Ref. 1; BAA13054)" FT /evidence="ECO:0000305" FT HELIX 8..11 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 12..19 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 22..31 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 35..41 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 50..53 FT /evidence="ECO:0007829|PDB:1U2E" FT TURN 54..57 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 58..63 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 67..71 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 88..102 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 108..113 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 115..126 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 128..130 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 131..138 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 146..148 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 153..163 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 167..175 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 186..198 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 200..212 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 221..226 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 231..236 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 240..242 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 245..253 FT /evidence="ECO:0007829|PDB:1U2E" FT STRAND 258..264 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 269..272 FT /evidence="ECO:0007829|PDB:1U2E" FT HELIX 274..285 FT /evidence="ECO:0007829|PDB:1U2E" SQ SEQUENCE 288 AA; 31937 MW; 8F7E5ADE584A45BA CRC64; MSYQPQTEAA TSRFLNVEEA GKTLRIHFND CGQGDETVVL LHGSGPGATG WANFSRNIDP LVEAGYRVIL LDCPGWGKSD SVVNSGSRSD LNARILKSVV DQLDIAKIHL LGNSMGGHSS VAFTLKWPER VGKLVLMGGG TGGMSLFTPM PTEGIKRLNQ LYRQPTIENL KLMMDIFVFD TSDLTDALFE ARLNNMLSRR DHLENFVKSL EANPKQFPDF GPRLAEIKAQ TLIVWGRNDR FVPMDAGLRL LSGIAGSELH IFRDCGHWAQ WEHADAFNQL VLNFLARP //